Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

  • M. Shahmanesh*
  • , H. Jaleel
  • , Y. DeSilva
  • , J. D.C. Ross
  • , M. Caslake
  • , R. Cramb
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    6 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)283-286
    Number of pages4
    JournalSexually Transmitted Infections
    Volume77
    Issue number4
    DOIs
    Publication statusPublished (VoR) - 2001

    Keywords

    • Apolipoprotein-E
    • HIV
    • Hyperlipidaemia
    • Protease inhibitors

    Fingerprint

    Dive into the research topics of 'Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype'. Together they form a unique fingerprint.

    Cite this